Use of masks indoors, home work and reduction of mass aggregations , as well as ventilation of closed environments and intensification of the fourth doses of the anti-Covid vaccine and a further dose for some categories at risk.

The Ministry of Health does not exclude a tightening on the anti-Covid regulations in the event of a worsening of the epidemiological situation , as stated in the circular "Interventions in place for the management of the circulation of SarsCoV2 in the 2022-23 winter season". The document provides ideas for "preparing a rapid adaptation of actions and services at the regional level in the event of an increased request for assistance".

The use of masks, the circular reads, "is effective in reducing the transmission of respiratory viruses and in the event that an evident epidemiological deterioration is documented with serious clinical impact and/or on the functioning of welfare services, their use in enclosed spaces, aimed in particular at protecting people at high risk of serious illness".

Similarly, " in the event of a possible significant worsening of the epidemiological picture , the temporary adoption of other measures could be evaluated, such as working from home or limiting the size of events involving gatherings ". At the moment in Italy the use of respiratory protective devices is mandatory for workers, users and visitors to healthcare facilities and nursing homes. The circular also calls for ensuring "adequate ventilation in closed environments, a fundamental measure to reduce the risk of transmission of SarsCoV2 and other respiratory viruses".

The ministry also recommends the anti-Covid vaccination in the 2022-2023 winter season, with the aim of " continuing to secure the elderly and frail as a priority, protecting them from serious illness and hospitalization ". The administration of the fourth doses with bivalent vaccines is recommended for categories at risk, and an additional booster dose with mRNA vaccine in the bivalent formulation «is currently recommended for the following categories of people who have already received a second booster dose with monovalent mRNA vaccine, once at least 120 days have passed since the same or since the last infection: people aged 80 and over, RSA guests, people aged 60 and over with frailty. At the request of the interested party, all the other over-60s who have already received a second booster can, however, also be vaccinated with a further dose of vaccine. Furthermore, from 09/12/22 the recommendation of the anti-Covid vaccination was extended to children in the 6 months - 4 years age group (included) who present frail conditions.

For the winter of 2022-23, it is still read, it is "essential that the regional health services verify and, if necessary, strengthen the state of preparation in order to face a possible increase in the demand for assistance for SarsCoV2 cases". Verification of hospitalization and intensive care beds is recommended ; the procurement of devices, drugs, vaccines; the availability of trained healthcare personnel who "can support local departments and services in the event of an increase in cases such as to exceed the current capacity of the healthcare systems".

CLASH WITH EUROPE - Meanwhile , from yesterday's press conference of the Prime Minister Giorgia Meloni comes the decisive yes to vaccines for the frail and elderly but leveraging on the sense of responsibility and not on coercion and full speed ahead with measures to stem arrivals from China where Covid has re-exploded , with the use of tampons for those arriving from China, masks and self-isolation.

But also a call to Europe: "Decisions on tampons for those arriving from China must be taken at the EU level". And if on the one hand the EU Health Security Committee says yes to concerted action on this very point, on the other a cold shower arrives from the European control centres, ECDC: the screening of travelers from China is "unjustified" . The EU countries "have relatively high levels of immunization and vaccination" and "the variants circulating in China are already in the EU, this measure is not necessary at the level of the European Union as a whole".

Even WHO Europe holds back , inviting not to discriminate against particular populations. The body also denounces a shortage of stocks of important drugs, including against Covid. The Chinese reaction was not long in coming which, on the measures taken by the "United States and other countries", says: "They are based on science and appropriate". Chinese Foreign Minister Wang Wenbin's spokesman stressed the need to "treat citizens of all countries fairly." Meanwhile, the issue is on the table of the British government which is evaluating the hypothesis of a path similar to that undertaken by Italy, while in the US the variant suspected of being responsible for the boom in cases in China is growing. By now one in 5 infected has fallen ill with XBB, known as Gryphon.

(Unioneonline/D)

© Riproduzione riservata